List of works by Harel Dahari

A Parameter Estimation Method for Multiscale Models of Hepatitis C Virus Dynamics

scientific article published on 23 July 2019

A Robust and Efficient Numerical Method for RNA-Mediated Viral Dynamics

scientific article published on 31 October 2017

A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease

scientific article

A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C

scientific article published on 31 January 2019

ANALYSIS OF HEPATITIS C VIRUS INFECTION MODELS WITH HEPATOCYTE HOMEOSTASIS

scientific article published on January 2009

Accounting for Space—Quantification of Cell-To-Cell Transmission Kinetics Using Virus Dynamics Models.

scientific article published on 17 April 2018

Acute HBV infection in humanized chimeric mice has multiphasic viral kinetics.

scientific article published on 23 March 2018

Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections

scientific article

Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model

scientific article

Antiviral action of ribavirin in chronic hepatitis C.

scientific article published on March 2004

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

scientific article published in July 2002

Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography

scientific article published on 07 February 2019

Cure prevents more than transmission of hepatitis C virus

scientific article published on 11 January 2016

Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed

scientific article published on 01 January 2021

Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis

scientific article published on 28 December 2018

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection

scientific article published on 15 March 2019

Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin

scientific article

Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.

scientific article published on 08 February 2013

Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics

scientific article published on 02 September 2020

End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals

scientific article

HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir.

scientific article published on 20 February 2016

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients

scientific article published on 7 December 2017

HCVMultiscaleFit: A Simulator For Parameter Estimation in Multiscale Models Of Hepatitis C Virus Dynamics

scientific article published on 25 November 2020

Hepatitis B virus clearance rate estimates

scientific article published in May 2009

Hepatitis C Viral Kinetics in Special Populations

scientific article published on January 2008

Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.

scientific article published on July 2011

Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)

scientific article published on 15 February 2012

Hepatitis C virus RNA kinetics: drug efficacy and the rate of HCV-infected cells loss

scientific article published on June 2007

Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.

scientific article published on July 2016

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees

scientific article published on June 2004

Hepatitis C virus kinetics in chimeric mice during antiviral therapy

scientific article published in December 2007

High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members

scientific article published on 5 September 2017

How to eliminate HCV in people who inject drugs in the USA.

scientific article

Individualized treatment for patients with low HCV load (genotype 1): a viral kinetic approach

scientific article published on 14 April 2014

Letter to the Editor: Examining HBV RNA kinetics during NA treatment - are NA multifunctional antiviral agents?

scientific article published on 13 November 2020

MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS

scientific article published on 01 December 2019

Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago

scientific article published on 21 August 2015

Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells

scientific article

Mathematical modeling of HCV infection and treatment

scientific article published on January 2009

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production

scientific article published in April 2005

Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection

scientific article

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins

scientific article

Modeling Challenges of Ebola Virus-Host Dynamics during Infection and Treatment

scientific article published on 16 January 2020

Modeling HCV cure after an ultra-short duration of therapy with direct acting agents

scientific article published on 30 June 2017

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

scientific article (publication date: July 2009)

Modeling based response guided therapy in subjects with recent hepatitis C infection

scientific article published on 24 June 2020

Modeling complex decay profiles of hepatitis B virus during antiviral therapy

scientific article published on January 2009

Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacy

scientific article

Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago

scientific article published on 05 April 2019

Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users

article

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

scientific article

Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography

scientific article published in PLoS ONE

Modeling suggests that virion production cycles within individual cells is key to understanding acute hepatitis B virus infection kinetics

scientific article published in 2023

Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection

scientific article published on 30 January 2013

Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration

scientific article published on 04 May 2020

Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay.

scientific article

Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg

scientific article published on 12 May 2020

Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.

scientific article published on September 2010

Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.

scientific article

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.

scientific article

Pharmacodynamics of PEG-IFN-[alpha]-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients

scientific article published on February 2011

Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes

scientific article

Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection.

scientific article published on 19 May 2017

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin

scientific article published on 09 July 2019

Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies

scientific article published on 17 October 2016

Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach

scientific article published on April 2015

Rapid emergence of protease inhibitor resistance in hepatitis C virus

scientific article

Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs

scientific article published on 13 March 2024

Reply: To PMID 25098971.

scientific article published on 18 April 2015

Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study

scientific article published on 20 October 2020

Resurrection of response-guided therapy for sofosbuvir combination therapies

scientific article published on 27 May 2016

Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

scientific article published on 13 January 2005

Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy

scientific article

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

scientific article published on 06 May 2020

Silibinin mode of action against hepatitis C virus: a controversy yet to be resolved

scientific article published on 27 June 2011

Silymarin for HCV infection

scientific article

Stress-Induced Epstein-Barr Virus Reactivation

scientific article published on 18 September 2021

Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection

scientific article published on 04 June 2020

Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics

scientific article

The extrahepatic contribution to HCV plasma viremia

scientific article published on 25 July 2006

The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate

scientific article

The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.

scientific article

Thiazole antibiotics against breast cancer

scientific article published on 15 March 2010

Treatment of hepatitis C with an interferon-based lead-in phase: a perspective from mathematical modelling

scientific article

Triphasic decline of hepatitis C virus RNA during antiviral therapy

scientific article published in July 2007

Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling

scientific article

Understanding silibinin's modes of action against HCV using viral kinetic modeling

scientific article published on 13 January 2012

Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy

scientific article published on 30 June 2011

Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling

scientific article published on 13 December 2012

Paulina is supported by:

About Paulina

Help